SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-017986
Filing Date
2020-09-17
Accepted
2020-09-17 20:08:25
Documents
1
Period of Report
2020-09-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5727
  Complete submission text file 0001493152-20-017986.txt   7848
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Reporting) CIK: 0001493215 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 201182427

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10019
Business Address
WONG RODERICK (Reporting) CIK: 0001493280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 201182428

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences